149 related articles for article (PubMed ID: 20680712)
1. Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer.
Fang YJ; Lu ZH; Wang F; Wu XJ; Li LR; Zhang LY; Pan ZZ; Wan DS
Tumour Biol; 2010 Dec; 31(6):651-8. PubMed ID: 20680712
[TBL] [Abstract][Full Text] [Related]
2. Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer.
Fang YJ; Wang GQ; Lu ZH; Zhang L; Li JB; Wu XJ; Ding PR; Ou QJ; Zhang MF; Jiang W; Pan ZZ; Wan DS
Tumour Biol; 2012 Dec; 33(6):2227-35. PubMed ID: 23055188
[TBL] [Abstract][Full Text] [Related]
3. Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer.
Fang YJ; Zhang L; Wu XJ; Lu ZH; Li JB; Ou QJ; Zhang MF; Ding PR; Pan ZZ; Wan DS
Tumour Biol; 2012 Dec; 33(6):1907-14. PubMed ID: 22836803
[TBL] [Abstract][Full Text] [Related]
4. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Fang YJ; Lu ZH; Wang GQ; Pan ZZ; Zhou ZW; Yun JP; Zhang MF; Wan DS
Int J Colorectal Dis; 2009 Aug; 24(8):875-84. PubMed ID: 19421758
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.
Huang Y; Yu H; Lei H; Xie C; Zhong Y
Med Oncol; 2014 Mar; 31(3):824. PubMed ID: 24469951
[TBL] [Abstract][Full Text] [Related]
6. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.
Klupp F; Neumann L; Kahlert C; Diers J; Halama N; Franz C; Schmidt T; Koch M; Weitz J; Schneider M; Ulrich A
BMC Cancer; 2016 Jul; 16():494. PubMed ID: 27431388
[TBL] [Abstract][Full Text] [Related]
8. MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells.
Fang YJ; Pan ZZ; Li LR; Lu ZH; Zhang LY; Wan DS
J Exp Clin Cancer Res; 2009 Sep; 28(1):132. PubMed ID: 19785773
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Yang B; Tang F; Zhang B; Zhao Y; Feng J; Rao Z
World J Surg Oncol; 2014 Jan; 12():24. PubMed ID: 24476461
[TBL] [Abstract][Full Text] [Related]
10. Gender-related survival differences associated with polymorphic variants of estrogen receptor-β (ERβ) in patients with metastatic colon cancer.
Press OA; Zhang W; Gordon MA; Yang D; Haiman CA; Azuma M; Iqbal S; Lenz HJ
Pharmacogenomics J; 2011 Oct; 11(5):375-82. PubMed ID: 20548329
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.
Konstantinopoulos PA; Kominea A; Vandoros G; Sykiotis GP; Andricopoulos P; Varakis I; Sotiropoulou-Bonikou G; Papavassiliou AG
Eur J Cancer; 2003 Jun; 39(9):1251-8. PubMed ID: 12763213
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive potential molecular biomarkers in colon cancer.
Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I
Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer].
Wang GQ; Lu ZH; Fang YJ; Chen G; Zhou ZW; Pan ZZ; Wan DS
Ai Zheng; 2009 Sep; 28(9):945-9. PubMed ID: 19728912
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
16. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
Peng Z; Chen J; Drachenberg CB; Raufman JP; Xie G
J Biol Chem; 2019 May; 294(21):8529-8542. PubMed ID: 30967475
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
[TBL] [Abstract][Full Text] [Related]
19. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L
Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells.
Edvardsson K; Nguyen-Vu T; Kalasekar SM; Pontén F; Gustafsson JÅ; Williams C
Carcinogenesis; 2013 Jul; 34(7):1431-41. PubMed ID: 23436804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
